2025艾尔建美学中国创新合作日成功举办

Core Insights - AbbVie’s global aesthetics leader, Allergan Aesthetics, is driving unprecedented innovation in China's aesthetic industry, aiming to collaborate with local biotech firms and industry platforms to foster high-quality technologies and solutions from China [1][2] Group 1: Event Overview - The "China Innovation Collaboration Day" hosted by Allergan Aesthetics in Shanghai gathered leaders from the medical aesthetics industry, investment sector, and upstream innovation fields to discuss trends, R&D progress, commercialization, and industry investment [1] - The event featured the launch of the "AbbVie China Innovation Award (Aesthetics Award)," which aims to identify and empower early-stage technologies and projects in the medical aesthetics sector [1][2] Group 2: Innovation Award Details - The innovation award will select promising early-stage biotech companies and provide a support package valued at 500,000 yuan, including access to high-standard laboratories, office space, R&D team support, and professional advice on R&D, production, quality, and compliance [2] - Allergan Aesthetics emphasizes the importance of aligning technological breakthroughs with localized service systems, aiming to create a sustainable and replicable innovation model in China [2] Group 3: Future Development Plans - Allergan Aesthetics plans to maintain an open collaboration approach, adhering to global quality and scientific standards while supporting the cultivation and development of high-quality local innovation projects [2]